Suzhou Basecare Medical Corp. Ltd. Class H

As of December 31, 2025, Suzhou Basecare Medical Corp. Ltd. Class H carries a market capitalization of 508.76M, placing it among publicly traded companies globally. Its enterprise value stands at 397.84M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Suzhou Basecare Medical Corp. Ltd. Class H's next confirmed earnings release is scheduled for April 1, 2027.

As of December 31, 2025, Suzhou Basecare Medical Corp. Ltd. Class H has 273.53M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Suzhou Basecare Medical Corp. Ltd. Class H maintains a current ratio of 3.98, meaning it holds 4.0x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, Suzhou Basecare Medical Corp. Ltd. Class H's stock has declined approximately 49.82% over the past 52 weeks. The 50-day moving average sits at 1.35, while the 200-day moving average is 1.67.

As of December 31, 2025, Suzhou Basecare Medical Corp. Ltd. Class H holds 493.04M in cash and equivalents against 382.12M in total debt, resulting in a net debt position of -82.60M. Total book value stands at 1.04B, with working capital of 630.46M providing operational flexibility.